| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycine binding | 4.64e-07 | 14 | 95 | 4 | GO:0016594 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated ion channel activity | 2.06e-06 | 6 | 95 | 3 | GO:0016933 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated chloride channel activity | 2.06e-06 | 6 | 95 | 3 | GO:0016934 | |
| GeneOntologyMolecularFunction | inhibitory extracellular ligand-gated monoatomic ion channel activity | 5.74e-06 | 8 | 95 | 3 | GO:0005237 | |
| GeneOntologyMolecularFunction | type I interferon receptor binding | 6.76e-05 | 17 | 95 | 3 | GO:0005132 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 9.36e-05 | 50 | 95 | 4 | GO:0099095 | |
| GeneOntologyMolecularFunction | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity | 1.34e-04 | 4 | 95 | 2 | GO:0003918 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.67e-04 | 171 | 95 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 2.61e-04 | 65 | 95 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 2.61e-04 | 65 | 95 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 3.28e-04 | 125 | 95 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | histone H3K27 methyltransferase activity | 3.32e-04 | 6 | 95 | 2 | GO:0046976 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.49e-04 | 196 | 95 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | amino acid binding | 4.07e-04 | 73 | 95 | 4 | GO:0016597 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 4.99e-04 | 77 | 95 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 5.61e-04 | 34 | 95 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 6.16e-04 | 8 | 95 | 2 | GO:0003916 | |
| GeneOntologyMolecularFunction | chloride channel activity | 7.58e-04 | 86 | 95 | 4 | GO:0005254 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 7.76e-04 | 151 | 95 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor | 7.89e-04 | 9 | 95 | 2 | GO:0016624 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 1.12e-03 | 43 | 95 | 3 | GO:0005231 | |
| GeneOntologyMolecularFunction | phosphatidylinositol transfer activity | 1.20e-03 | 11 | 95 | 2 | GO:0008526 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.20e-03 | 44 | 95 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.33e-03 | 100 | 95 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 1.48e-03 | 103 | 95 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.30e-03 | 193 | 95 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.51e-03 | 197 | 95 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 2.53e-03 | 57 | 95 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | ribosome binding | 2.59e-03 | 120 | 95 | 4 | GO:0043022 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 2.93e-03 | 60 | 95 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 3.26e-03 | 18 | 95 | 2 | GO:0015347 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 4.02e-03 | 20 | 95 | 2 | GO:0061665 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 4.02e-03 | 20 | 95 | 2 | GO:0008525 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 4.18e-03 | 68 | 95 | 3 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 4.36e-03 | 69 | 95 | 3 | GO:0016278 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 4.54e-03 | 70 | 95 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 4.72e-03 | 71 | 95 | 3 | GO:0042054 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 5.10e-03 | 73 | 95 | 3 | GO:0170055 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 5.30e-03 | 74 | 95 | 3 | GO:0005548 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 5.50e-03 | 75 | 95 | 3 | GO:0098960 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 7.55e-06 | 9 | 94 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 2.06e-05 | 183 | 94 | 7 | GO:0006820 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | DIP2B PPP2R5B ATR PDGFRA TTLL2 TRPC6 LRRK2 EHMT1 GCSH METTL23 PIAS2 PIAS1 IFNA7 IFNA14 IFNA16 | 3.35e-05 | 976 | 94 | 15 | GO:0018193 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 7.18e-05 | 153 | 94 | 6 | GO:0098656 | |
| GeneOntologyBiologicalProcess | protein insertion into membrane | 7.93e-05 | 50 | 94 | 4 | GO:0051205 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine modification | 9.85e-05 | 162 | 94 | 6 | GO:0018205 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 1.15e-04 | 21 | 94 | 3 | GO:0033141 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum organization | 1.30e-04 | 107 | 94 | 5 | GO:0007029 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 1.61e-04 | 112 | 94 | 5 | GO:1902476 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 1.73e-04 | 24 | 94 | 3 | GO:0033139 | |
| GeneOntologyBiologicalProcess | chylomicron assembly | 2.04e-04 | 5 | 94 | 2 | GO:0034378 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glycinergic | 2.04e-04 | 5 | 94 | 2 | GO:0060012 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 2.76e-04 | 28 | 94 | 3 | GO:0042501 | |
| GeneOntologyBiologicalProcess | chloride transport | 3.00e-04 | 128 | 94 | 5 | GO:0006821 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 3.71e-04 | 134 | 94 | 5 | GO:0098661 | |
| GeneOntologyBiologicalProcess | protein insertion into ER membrane | 3.76e-04 | 31 | 94 | 3 | GO:0045048 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 7.49e-06 | 9 | 95 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | glycine-gated chloride channel complex | 2.04e-05 | 2 | 95 | 2 | GO:0016935 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 3.19e-05 | 14 | 95 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | glycinergic synapse | 9.80e-05 | 20 | 95 | 3 | GO:0098690 | |
| Domain | DUF2012 | 4.76e-07 | 4 | 93 | 3 | PF09430 | |
| Domain | DUF2012 | 4.76e-07 | 4 | 93 | 3 | IPR019008 | |
| Domain | Carb-bd-like_fold | 6.57e-06 | 8 | 93 | 3 | IPR013784 | |
| Domain | CarboxyPept_regulatory_dom | 3.30e-05 | 13 | 93 | 3 | IPR014766 | |
| Domain | - | 3.30e-05 | 13 | 93 | 3 | 2.60.40.1120 | |
| Domain | Band_7/stomatin-like_CS | 7.33e-05 | 3 | 93 | 2 | IPR018080 | |
| Domain | BAND_7 | 7.33e-05 | 3 | 93 | 2 | PS01270 | |
| Domain | Interferon_alpha/beta/delta | 7.73e-05 | 17 | 93 | 3 | IPR000471 | |
| Domain | CarboxyPept-like_regulatory | 7.73e-05 | 17 | 93 | 3 | IPR008969 | |
| Domain | Interferon | 7.73e-05 | 17 | 93 | 3 | PF00143 | |
| Domain | IFabd | 7.73e-05 | 17 | 93 | 3 | SM00076 | |
| Domain | INTERFERON_A_B_D | 7.73e-05 | 17 | 93 | 3 | PS00252 | |
| Domain | PINIT | 1.46e-04 | 4 | 93 | 2 | IPR023321 | |
| Domain | Glycine_rcpt_A | 1.46e-04 | 4 | 93 | 2 | IPR008127 | |
| Domain | PINIT | 1.46e-04 | 4 | 93 | 2 | PS51466 | |
| Domain | PINIT | 1.46e-04 | 4 | 93 | 2 | PF14324 | |
| Domain | Stomatin_fam | 2.43e-04 | 5 | 93 | 2 | IPR001972 | |
| Domain | IP_trans | 2.43e-04 | 5 | 93 | 2 | PF02121 | |
| Domain | PI_transfer | 3.63e-04 | 6 | 93 | 2 | IPR001666 | |
| Domain | DDHD | 3.63e-04 | 6 | 93 | 2 | PF02862 | |
| Domain | DDHD | 3.63e-04 | 6 | 93 | 2 | PS51043 | |
| Domain | DDHD_dom | 3.63e-04 | 6 | 93 | 2 | IPR004177 | |
| Domain | DDHD | 3.63e-04 | 6 | 93 | 2 | SM01127 | |
| Domain | TGS-like | 5.07e-04 | 7 | 93 | 2 | IPR012676 | |
| Domain | zf-MIZ | 5.07e-04 | 7 | 93 | 2 | PF02891 | |
| Domain | ZF_SP_RING | 5.07e-04 | 7 | 93 | 2 | PS51044 | |
| Domain | Man6P_isomerase_rcpt-bd_dom | 6.74e-04 | 8 | 93 | 2 | IPR009011 | |
| Domain | Transket_pyr | 6.74e-04 | 8 | 93 | 2 | SM00861 | |
| Domain | Transket_pyr | 6.74e-04 | 8 | 93 | 2 | PF02779 | |
| Domain | Znf_MIZ | 6.74e-04 | 8 | 93 | 2 | IPR004181 | |
| Domain | Transketolase-like_Pyr-bd | 6.74e-04 | 8 | 93 | 2 | IPR005475 | |
| Domain | HAT | 1.08e-03 | 10 | 93 | 2 | IPR003107 | |
| Domain | HAT | 1.08e-03 | 10 | 93 | 2 | SM00386 | |
| Domain | Band_7 | 1.31e-03 | 11 | 93 | 2 | IPR001107 | |
| Domain | Band_7 | 1.31e-03 | 11 | 93 | 2 | PF01145 | |
| Domain | PHB | 1.31e-03 | 11 | 93 | 2 | SM00244 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.46e-03 | 45 | 93 | 3 | IPR018000 | |
| Domain | ARM-type_fold | 1.52e-03 | 339 | 93 | 7 | IPR016024 | |
| Domain | Neur_chan_memb | 1.55e-03 | 46 | 93 | 3 | PF02932 | |
| Domain | OA_transporter | 1.57e-03 | 12 | 93 | 2 | IPR004156 | |
| Domain | OATP | 1.57e-03 | 12 | 93 | 2 | PF03137 | |
| Domain | Neur_chan_LBD | 1.65e-03 | 47 | 93 | 3 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 1.65e-03 | 47 | 93 | 3 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 1.65e-03 | 47 | 93 | 3 | IPR006029 | |
| Domain | - | 1.65e-03 | 47 | 93 | 3 | 2.70.170.10 | |
| Domain | Neur_channel | 1.65e-03 | 47 | 93 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.65e-03 | 47 | 93 | 3 | IPR006202 | |
| Domain | - | ADAMTSL1 PDGFRA MYCBP2 NOMO2 ADAMTSL3 IL1RAP IL22RA1 F13A1 NOMO3 NOMO1 | 1.69e-03 | 663 | 93 | 10 | 2.60.40.10 |
| Domain | THDP-binding | 1.85e-03 | 13 | 93 | 2 | IPR029061 | |
| Domain | - | 1.85e-03 | 13 | 93 | 2 | 3.40.50.970 | |
| Domain | - | 1.98e-03 | 50 | 93 | 3 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine_core | 2.09e-03 | 51 | 93 | 3 | IPR012351 | |
| Domain | Kazal_dom | 2.09e-03 | 51 | 93 | 3 | IPR002350 | |
| Domain | Beta-grasp_dom | 2.15e-03 | 14 | 93 | 2 | IPR012675 | |
| Domain | PLAC | 2.15e-03 | 14 | 93 | 2 | PF08686 | |
| Domain | - | 2.15e-03 | 14 | 93 | 2 | 3.10.20.30 | |
| Domain | Ig-like_fold | ADAMTSL1 PDGFRA MYCBP2 NOMO2 ADAMTSL3 IL1RAP IL22RA1 F13A1 NOMO3 NOMO1 | 2.68e-03 | 706 | 93 | 10 | IPR013783 |
| Domain | PLAC | 3.97e-03 | 19 | 93 | 2 | PS50900 | |
| Domain | PLAC | 3.97e-03 | 19 | 93 | 2 | IPR010909 | |
| Domain | - | 4.84e-03 | 21 | 93 | 2 | 1.10.720.30 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 5.80e-05 | 41 | 73 | 4 | MM1493 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 8.60e-05 | 17 | 73 | 3 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 1.03e-04 | 18 | 73 | 3 | M47539 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 1.22e-04 | 19 | 73 | 3 | MM1571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 1.22e-04 | 19 | 73 | 3 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING | 1.43e-04 | 20 | 73 | 3 | M47876 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 1.43e-04 | 20 | 73 | 3 | M47617 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 1.49e-04 | 155 | 73 | 6 | M17411 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 1.66e-04 | 21 | 73 | 3 | M47909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 1.91e-04 | 22 | 73 | 3 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 1.91e-04 | 22 | 73 | 3 | M47616 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 2.19e-04 | 23 | 73 | 3 | M47452 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 2.19e-04 | 23 | 73 | 3 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 2.49e-04 | 24 | 73 | 3 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 2.49e-04 | 24 | 73 | 3 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 2.49e-04 | 24 | 73 | 3 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 3.18e-04 | 26 | 73 | 3 | M982 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 3.98e-04 | 28 | 73 | 3 | MM1378 | |
| Pathway | KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION | 4.24e-04 | 264 | 73 | 7 | M9809 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 4.89e-04 | 30 | 73 | 3 | M936 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 5.40e-04 | 31 | 73 | 3 | M39897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 5.40e-04 | 31 | 73 | 3 | M47964 | |
| Pathway | REACTOME_GLYCINE_DEGRADATION | 5.46e-04 | 7 | 73 | 2 | M48229 | |
| Pathway | REACTOME_GLYCINE_DEGRADATION | 5.46e-04 | 7 | 73 | 2 | MM17221 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 6.50e-04 | 33 | 73 | 3 | MM1379 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 7.10e-04 | 34 | 73 | 3 | MM15631 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 7.74e-04 | 35 | 73 | 3 | M48246 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 7.74e-04 | 35 | 73 | 3 | M6382 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 9.12e-04 | 37 | 73 | 3 | M39785 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 1.07e-03 | 39 | 73 | 3 | MM15914 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.07e-03 | 39 | 73 | 3 | M27238 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.41e-03 | 11 | 73 | 2 | M22027 | |
| Pathway | PID_RANBP2_PATHWAY | 1.41e-03 | 11 | 73 | 2 | M140 | |
| Pathway | KEGG_LYSINE_DEGRADATION | 1.52e-03 | 44 | 73 | 3 | M13720 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 1.69e-03 | 12 | 73 | 2 | MM15476 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.72e-03 | 99 | 73 | 4 | MM14910 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.83e-03 | 47 | 73 | 3 | MM14939 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 2.21e-03 | 106 | 73 | 4 | M27200 | |
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 1.97e-08 | 3 | 95 | 3 | 25576386 | |
| Pubmed | 7.88e-08 | 4 | 95 | 3 | 9051263 | ||
| Pubmed | 7.88e-08 | 4 | 95 | 3 | 21486797 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 7.88e-08 | 4 | 95 | 3 | 31833031 | |
| Pubmed | Alpha subunit-dependent glycine receptor clustering and regulation of synaptic receptor numbers. | 7.88e-08 | 4 | 95 | 3 | 28883437 | |
| Pubmed | 7.88e-08 | 4 | 95 | 3 | 9267806 | ||
| Pubmed | 9.27e-08 | 16 | 95 | 4 | 3100390 | ||
| Pubmed | Developmental regulation of glycine receptors at efferent synapses of the murine cochlea. | 1.97e-07 | 5 | 95 | 3 | 21850450 | |
| Pubmed | 1.97e-07 | 5 | 95 | 3 | 24194565 | ||
| Pubmed | Native glycine receptor subtypes and their physiological roles. | 1.97e-07 | 5 | 95 | 3 | 18721822 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 1.09e-06 | 8 | 95 | 3 | 15257293 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 1.64e-06 | 9 | 95 | 3 | 36261522 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 3.21e-06 | 11 | 95 | 3 | 8389790 | |
| Pubmed | 3.21e-06 | 11 | 95 | 3 | 18835032 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 3.21e-06 | 11 | 95 | 3 | 6444699 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 3.21e-06 | 11 | 95 | 3 | 3456887 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 3.21e-06 | 11 | 95 | 3 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 3.21e-06 | 11 | 95 | 3 | 15795237 | |
| Pubmed | 3.21e-06 | 11 | 95 | 3 | 9794439 | ||
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 3.21e-06 | 11 | 95 | 3 | 32820719 | |
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 3.21e-06 | 11 | 95 | 3 | 10448195 | |
| Pubmed | 3.21e-06 | 11 | 95 | 3 | 25310498 | ||
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 3.21e-06 | 11 | 95 | 3 | 19120292 | |
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 16565497 | ||
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 22685550 | ||
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 3017340 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 4.27e-06 | 12 | 95 | 3 | 21320124 | |
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 4.27e-06 | 12 | 95 | 3 | 33123150 | |
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 20038206 | ||
| Pubmed | Murine alpha/beta interferons inhibit benzo(a)pyrene activation and mutagenesis in mice. | 4.27e-06 | 12 | 95 | 3 | 8304945 | |
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 11846978 | ||
| Pubmed | A novel anti-viral role for STAT3 in IFN-α signalling responses. | 4.27e-06 | 12 | 95 | 3 | 27988795 | |
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 4.27e-06 | 12 | 95 | 3 | 8760352 | |
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 4.27e-06 | 12 | 95 | 3 | 17512142 | |
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 8656058 | ||
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 4.27e-06 | 12 | 95 | 3 | 1886773 | |
| Pubmed | Behavioral effects of mouse interferons-alpha and -gamma and human interferon-alpha in mice. | 4.27e-06 | 12 | 95 | 3 | 1422836 | |
| Pubmed | The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. | 4.27e-06 | 12 | 95 | 3 | 2572648 | |
| Pubmed | Developmental control of IFN-alpha expression in murine embryos. | 4.27e-06 | 12 | 95 | 3 | 7925651 | |
| Pubmed | The role of type 1 interferons in coagulation induced by gram-negative bacteria. | 4.27e-06 | 12 | 95 | 3 | 32016282 | |
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 4.27e-06 | 12 | 95 | 3 | 7530016 | |
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 17277125 | ||
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 9794206 | ||
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 4.27e-06 | 12 | 95 | 3 | 7684767 | |
| Pubmed | Isolation and mapping of four new DNA markers from mouse chromosome 4. | 4.27e-06 | 12 | 95 | 3 | 1360280 | |
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 6188104 | ||
| Pubmed | Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells. | 4.27e-06 | 12 | 95 | 3 | 26277892 | |
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 6689487 | ||
| Pubmed | Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. | 4.27e-06 | 12 | 95 | 3 | 18716002 | |
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 17451966 | ||
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 25897172 | ||
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 4.27e-06 | 12 | 95 | 3 | 16611902 | |
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 30967261 | ||
| Pubmed | A polymorphic trinucleotide repeat sequence mapping to distal mouse chromosome 4. | 4.27e-06 | 12 | 95 | 3 | 8672140 | |
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 4.27e-06 | 12 | 95 | 3 | 22912583 | |
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 23747509 | ||
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 17434974 | ||
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 18937499 | ||
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 4.27e-06 | 12 | 95 | 3 | 3758677 | |
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 7601556 | ||
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 19406830 | ||
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 8245849 | ||
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 5.54e-06 | 13 | 95 | 3 | 12930842 | |
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 23804712 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 22431588 | ||
| Pubmed | Mouse interferon alpha and beta genes are linked at the centromere proximal region of chromosome 4. | 5.54e-06 | 13 | 95 | 3 | 3973562 | |
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 5.54e-06 | 13 | 95 | 3 | 2014240 | |
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 18005734 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 12050368 | ||
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 5.54e-06 | 13 | 95 | 3 | 2987810 | |
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 5.54e-06 | 13 | 95 | 3 | 6094686 | |
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 2993652 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 19130550 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 1655578 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 21469099 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 2471809 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 22739040 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 21263073 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 8438572 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 38660315 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 9343822 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 20065291 | ||
| Pubmed | Effects of IFN alpha on late stages of HIV-1 replication cycle. | 5.54e-06 | 13 | 95 | 3 | 9865497 | |
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 9181467 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 5.54e-06 | 13 | 95 | 3 | 23255800 | |
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 17723216 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 7523540 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 7510216 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 19635904 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 20427526 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 5.54e-06 | 13 | 95 | 3 | 18726328 | |
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 19706714 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 18572754 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 15723075 | ||
| Pubmed | 7.03e-06 | 14 | 95 | 3 | 14983024 | ||
| Pubmed | 7.03e-06 | 14 | 95 | 3 | 22815848 | ||
| Pubmed | 7.03e-06 | 14 | 95 | 3 | 22095711 | ||
| Pubmed | Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling. | 7.03e-06 | 14 | 95 | 3 | 18981154 | |
| Pubmed | 7.03e-06 | 14 | 95 | 3 | 1442307 | ||
| Cytoband | 9p22 | 1.91e-05 | 25 | 95 | 3 | 9p22 | |
| GeneFamily | Glycine receptors | 6.02e-07 | 5 | 72 | 3 | 868 | |
| GeneFamily | Phosphatidylinositol transfer proteins | 2.32e-04 | 6 | 72 | 2 | 1151 | |
| GeneFamily | Interferons | 2.76e-04 | 32 | 72 | 3 | 598 | |
| GeneFamily | ADAMTS like | 3.24e-04 | 7 | 72 | 2 | 947 | |
| GeneFamily | Zinc fingers MIZ-type | 3.24e-04 | 7 | 72 | 2 | 85 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 1.59e-03 | 15 | 72 | 2 | 696 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.86e-06 | 185 | 95 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 3.23e-06 | 189 | 95 | 6 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-06 | 196 | 95 | 6 | 36ed1918f70b6f5760bb088b15ce422998055cc7 | |
| ToppCell | medial-Epithelial-Ciliated-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.35e-06 | 199 | 95 | 6 | 526002f16bbf61cf086278d45a401cc0b0b757a8 | |
| ToppCell | medial-Epithelial-Ciliated|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.35e-06 | 199 | 95 | 6 | a2daa42b100c422dc8c04fb7d2ebf54293eef574 | |
| ToppCell | medial-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.35e-06 | 199 | 95 | 6 | c02f04a5aa79ee0cf427f6e94b93ceab38ebbcd7 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 4.35e-06 | 199 | 95 | 6 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 4.35e-06 | 199 | 95 | 6 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | distal-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.35e-06 | 199 | 95 | 6 | 97b66b82c76c7bc1fcd7da7b94dd2aa2d4d70a60 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.69e-05 | 164 | 95 | 5 | 0662cd9d21608efacc336e0a582859f3b9a4951d | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-05 | 168 | 95 | 5 | 2082b15fc7935a211f1c61506b305af5501a21ad | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-05 | 173 | 95 | 5 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-05 | 173 | 95 | 5 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 3.67e-05 | 175 | 95 | 5 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.77e-05 | 176 | 95 | 5 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.09e-05 | 179 | 95 | 5 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 4.20e-05 | 180 | 95 | 5 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | Adult-Immune-natural_killer_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.20e-05 | 180 | 95 | 5 | fc59e28f39e7d4fb1bcc7205202cf39224b70d7b | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 4.20e-05 | 180 | 95 | 5 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.42e-05 | 182 | 95 | 5 | 975f6275777fc578eba528e50f69891c66ec44ad | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.42e-05 | 182 | 95 | 5 | f8c28fa76751062c4cfba0db8af1b377f947f739 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.54e-05 | 183 | 95 | 5 | 807d64deaf4e50dccf6f831f88578a6d903c1421 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-Tregs|blood / Manually curated celltypes from each tissue | 4.66e-05 | 184 | 95 | 5 | 22c15ce30171c687ab564f4383ae74d38b759272 | |
| ToppCell | COVID-cycling-|COVID / Condition, Cell_class and T cell subcluster | 4.78e-05 | 185 | 95 | 5 | eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 4.78e-05 | 185 | 95 | 5 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | COVID-cycling|COVID / Condition, Cell_class and T cell subcluster | 4.78e-05 | 185 | 95 | 5 | 5112f966735fa48f0606adcfd5c0212ad5d3d77a | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.91e-05 | 186 | 95 | 5 | 76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.91e-05 | 186 | 95 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.03e-05 | 187 | 95 | 5 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 187 | 95 | 5 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 5.03e-05 | 187 | 95 | 5 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.16e-05 | 188 | 95 | 5 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.29e-05 | 189 | 95 | 5 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | COVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 5.29e-05 | 189 | 95 | 5 | 2c018d6120f65f0b2704b483bc9da1c0984872e3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.29e-05 | 189 | 95 | 5 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 5.29e-05 | 189 | 95 | 5 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.43e-05 | 190 | 95 | 5 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.43e-05 | 190 | 95 | 5 | 169e600e95878000acf5d11f813f9028c7249646 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.43e-05 | 190 | 95 | 5 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.43e-05 | 190 | 95 | 5 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 5.43e-05 | 190 | 95 | 5 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 5.43e-05 | 190 | 95 | 5 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | Ciliated_cells-A|World / lung cells shred on cell class, cell subclass, sample id | 5.43e-05 | 190 | 95 | 5 | cd87731aaa7d252424f79cfce9f7931457f17bdf | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 5.56e-05 | 191 | 95 | 5 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.70e-05 | 192 | 95 | 5 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | LAM-Epithelial-AirwayEpi|LAM / Condition, Lineage and Cell class | 5.70e-05 | 192 | 95 | 5 | 7404fc65be3b7bd09447725b43fa31819004dfee | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 193 | 95 | 5 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.84e-05 | 193 | 95 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Megakaryocyte|World / Lineage, cell class and subclass | 5.84e-05 | 193 | 95 | 5 | 352cd442b6e62f09b6d22a139774067873644594 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.84e-05 | 193 | 95 | 5 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.99e-05 | 194 | 95 | 5 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 5.99e-05 | 194 | 95 | 5 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.99e-05 | 194 | 95 | 5 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.99e-05 | 194 | 95 | 5 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 194 | 95 | 5 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.14e-05 | 195 | 95 | 5 | e525b69145059b66417589601f7109af63730f3a | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.14e-05 | 195 | 95 | 5 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.14e-05 | 195 | 95 | 5 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.14e-05 | 195 | 95 | 5 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.14e-05 | 195 | 95 | 5 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.14e-05 | 195 | 95 | 5 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.14e-05 | 195 | 95 | 5 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-T4_reg-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.14e-05 | 195 | 95 | 5 | 911a37684c1f93d537f51ee71cb1ccec06840315 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-05 | 195 | 95 | 5 | 47a01b8a92eebeb34ac7f70bf1ab4613a326e24f | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.44e-05 | 197 | 95 | 5 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.44e-05 | 197 | 95 | 5 | 861e8df9bd74dc5e17bafdc1fb3fef546753c73a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.44e-05 | 197 | 95 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.60e-05 | 198 | 95 | 5 | 16c54b884500066ade05a406915f9569ca8abdfc | |
| ToppCell | Transverse-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 6.75e-05 | 199 | 95 | 5 | 7cfe9b2538ea008d67343f3e8bfec3bf81200de6 | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.75e-05 | 199 | 95 | 5 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.75e-05 | 199 | 95 | 5 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 | |
| ToppCell | distal-Epithelial-Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.75e-05 | 199 | 95 | 5 | 18ca031cfe702afb9bf94e03c0f3680c38e7599e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.75e-05 | 199 | 95 | 5 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | distal-1-Epithelial-Ciliated|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.75e-05 | 199 | 95 | 5 | 4120e4a2bc05adebe1e1e9670ed7ea55142eb83d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.75e-05 | 199 | 95 | 5 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.75e-05 | 199 | 95 | 5 | 86f2857ce60fbe59375411373ff49c684fd66ad0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.75e-05 | 199 | 95 | 5 | fba48342066aab41a8bcb20db40a6df0158e1cbe | |
| ToppCell | Transverse-T_cell-Tfh|T_cell / Region, Cell class and subclass | 6.75e-05 | 199 | 95 | 5 | 33ffea12b8228e0b5bd8942531c3b21d24224725 | |
| ToppCell | (1)_T_cell-(18)_cycling_gd_T|(1)_T_cell / shred on Cell_type and subtype | 6.75e-05 | 199 | 95 | 5 | 9369d0e4efe809e3e8757294ebebba5a47b30528 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Ventral_Precursors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.92e-05 | 200 | 95 | 5 | c8ea0db79b1521f8c90d0d749280c354d3907c3a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 6.92e-05 | 200 | 95 | 5 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-05 | 200 | 95 | 5 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors_nGenesUnder4k|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.92e-05 | 200 | 95 | 5 | 8223d2c9b9e05b1d26e3de1bc0226d175af2e7b2 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.92e-05 | 200 | 95 | 5 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 6.92e-05 | 200 | 95 | 5 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.92e-05 | 200 | 95 | 5 | dd5b753bb1333fa502b9d3a6d65a53a9882b2451 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-05 | 200 | 95 | 5 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-05 | 200 | 95 | 5 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | control-gd_T|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.92e-05 | 200 | 95 | 5 | b188f2acb9bd4f5f1ad4c3d3ddb9a55854a8b74b | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-05 | 200 | 95 | 5 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-T/NK_proliferative|IIF / Disease, condition lineage and cell class | 6.92e-05 | 200 | 95 | 5 | c7c1806a1054b2b034a26a18aac93fc3bec4dbc8 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.92e-05 | 200 | 95 | 5 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.92e-05 | 200 | 95 | 5 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.92e-05 | 200 | 95 | 5 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Intermediate|3m / Sample Type, Dataset, Time_group, and Cell type. | 6.92e-05 | 200 | 95 | 5 | cbd0b9188a94778ffa539912aeb2a4378f0ab88f | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Ccnb1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.68e-04 | 129 | 95 | 4 | ff74d159034a09f7b174da18bfb9a26936252b4c | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.94e-04 | 134 | 95 | 4 | 2647453f44b0e0a8f27ef9bba750e99eb40efc8b | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.36e-04 | 141 | 95 | 4 | 399380de5ea09e22fd128e3e55fffeffc4874c15 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-C_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.49e-04 | 143 | 95 | 4 | b74571d30def54a0524c8d95a3bc9d3439319eb4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-C_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.49e-04 | 143 | 95 | 4 | 5c81b238be53f010d691d0c59c1c29cb52222ed3 | |
| Computational | Neurotransmitter (GABA) receptor. | 6.82e-05 | 15 | 59 | 3 | MODULE_215 | |
| Computational | Genes in the cancer module 141. | 8.36e-05 | 16 | 59 | 3 | MODULE_141 | |
| Computational | Neighborhood of MLLT10 | 2.26e-04 | 302 | 59 | 8 | MORF_MLLT10 | |
| Computational | Neighborhood of PTPRR | 2.33e-04 | 102 | 59 | 5 | MORF_PTPRR | |
| Computational | Ion channels. | 4.18e-04 | 27 | 59 | 3 | MODULE_214 | |
| Computational | Neighborhood of CTSB | 5.36e-04 | 187 | 59 | 6 | MORF_CTSB | |
| Drug | PK 8165 | 9.86e-09 | 7 | 95 | 4 | CID000071219 | |
| Drug | Glycine | 1.49e-07 | 30 | 95 | 5 | DB00145 | |
| Drug | iso-THAZ | 2.81e-07 | 4 | 95 | 3 | CID003047783 | |
| Drug | protostrychnine | 2.81e-07 | 4 | 95 | 3 | CID005320746 | |
| Drug | 7-nitroindoline | 2.81e-07 | 4 | 95 | 3 | CID013566747 | |
| Drug | 2-(phosphonomethyl)phenylalanine | 2.81e-07 | 4 | 95 | 3 | CID000383689 | |
| Drug | SC-49648 | 2.81e-07 | 4 | 95 | 3 | CID000195696 | |
| Drug | akuammiline | 2.81e-07 | 4 | 95 | 3 | CID005367018 | |
| Drug | NSC381080 | 2.81e-07 | 4 | 95 | 3 | CID000165497 | |
| Drug | N-methyl-THIP | 2.81e-07 | 4 | 95 | 3 | CID000134373 | |
| Drug | SC-48981 | 2.81e-07 | 4 | 95 | 3 | CID000126573 | |
| Drug | SC-50132 | 2.81e-07 | 4 | 95 | 3 | CID000195719 | |
| Drug | SR 42641 | 2.81e-07 | 4 | 95 | 3 | CID000129049 | |
| Drug | ACEA-1011 | 3.75e-07 | 15 | 95 | 4 | CID000127872 | |
| Drug | LY233536 | 4.98e-07 | 16 | 95 | 4 | CID000126239 | |
| Drug | 7-Cl-Thio-Kyna | 6.49e-07 | 17 | 95 | 4 | CID003035668 | |
| Drug | azetidine-3-carboxylic acid | 6.99e-07 | 5 | 95 | 3 | CID000093192 | |
| Drug | Lindane | 6.99e-07 | 5 | 95 | 3 | DB00431 | |
| Drug | Cao C | 6.99e-07 | 5 | 95 | 3 | CID000166617 | |
| Drug | oxanilide | 6.99e-07 | 5 | 95 | 3 | CID000069288 | |
| Drug | iso-THAO | 6.99e-07 | 5 | 95 | 3 | CID000127199 | |
| Drug | ALX1393 | 6.99e-07 | 5 | 95 | 3 | CID016078939 | |
| Drug | pleiocarpamine | 6.99e-07 | 5 | 95 | 3 | CID000558637 | |
| Drug | mafoprazine | 6.99e-07 | 5 | 95 | 3 | CID000071241 | |
| Drug | gevotroline | 6.99e-07 | 5 | 95 | 3 | CID000060546 | |
| Drug | MNQX | 8.32e-07 | 18 | 95 | 4 | CID000130818 | |
| Drug | THAZ | 1.39e-06 | 6 | 95 | 3 | CID000171289 | |
| Drug | mV GABA | 1.39e-06 | 6 | 95 | 3 | CID000128435 | |
| Drug | caged glycine | 1.39e-06 | 6 | 95 | 3 | CID000192642 | |
| Drug | brometone | 1.39e-06 | 6 | 95 | 3 | CID000006424 | |
| Drug | minaxolone | 1.39e-06 | 6 | 95 | 3 | CID000071960 | |
| Drug | thiomuscimol | 1.39e-06 | 6 | 95 | 3 | CID000005448 | |
| Drug | thio-THIP | 1.39e-06 | 6 | 95 | 3 | CID000656720 | |
| Drug | AC1L90PQ | 1.39e-06 | 6 | 95 | 3 | CID000436036 | |
| Drug | alpha-EMTBL | 2.43e-06 | 7 | 95 | 3 | CID000128423 | |
| Drug | CID189778 | 2.43e-06 | 7 | 95 | 3 | CID000189778 | |
| Drug | propyl methanethiosulfonate | 2.43e-06 | 7 | 95 | 3 | CID000529387 | |
| Drug | thiocolchicoside | 2.43e-06 | 7 | 95 | 3 | CID000072067 | |
| Drug | L-serinamide | 2.43e-06 | 7 | 95 | 3 | CID000101138 | |
| Drug | Boc-glycine | 2.43e-06 | 7 | 95 | 3 | CID000078288 | |
| Drug | SL 75102 | 2.83e-06 | 24 | 95 | 4 | CID005751746 | |
| Drug | WT702 | 3.88e-06 | 8 | 95 | 3 | CID000089643 | |
| Drug | isostrychnine | 3.88e-06 | 8 | 95 | 3 | CID000264626 | |
| Drug | L-689,560 | 4.64e-06 | 27 | 95 | 4 | CID000121918 | |
| Drug | Atonik | 5.80e-06 | 9 | 95 | 3 | CID000069471 | |
| Drug | nortropanol | 5.80e-06 | 9 | 95 | 3 | CID000068147 | |
| Drug | AC1NSJX8 | 5.80e-06 | 9 | 95 | 3 | CID005311059 | |
| Drug | NSC129536 | 5.80e-06 | 9 | 95 | 3 | CID000004815 | |
| Drug | SR 57227A | 5.80e-06 | 9 | 95 | 3 | CID000131746 | |
| Drug | DCQX | 5.80e-06 | 9 | 95 | 3 | CID000001845 | |
| Drug | AC1NUW3V | 6.24e-06 | 29 | 95 | 4 | CID005462126 | |
| Drug | LY235959 | 8.21e-06 | 31 | 95 | 4 | CID000131938 | |
| Drug | NPC 12626 | 8.21e-06 | 31 | 95 | 4 | CID000108099 | |
| Drug | eliprodil | 8.21e-06 | 31 | 95 | 4 | CID000060703 | |
| Drug | THBA | 8.27e-06 | 10 | 95 | 3 | CID000130993 | |
| Drug | L-cycloserine | 8.31e-06 | 66 | 95 | 5 | CID000000401 | |
| Drug | 1-aminocyclopropane-1-carboxylic acid | 8.35e-06 | 114 | 95 | 6 | CID000000535 | |
| Drug | indole-2-carboxylic acid | 9.35e-06 | 32 | 95 | 4 | CID000072899 | |
| Drug | ip 0 | 1.13e-05 | 11 | 95 | 3 | CID000006943 | |
| Drug | colchicoside | 1.51e-05 | 12 | 95 | 3 | CID000092763 | |
| Drug | C6H12NO5P | 1.51e-05 | 36 | 95 | 4 | CID000104962 | |
| Drug | NSC-88789 | 2.09e-05 | 39 | 95 | 4 | CID000002748 | |
| Drug | HA-966 | 2.09e-05 | 39 | 95 | 4 | CID000001232 | |
| Drug | ABPH | 2.48e-05 | 14 | 95 | 3 | CID000092377 | |
| Drug | quinoxaline-2,3-dione | 2.48e-05 | 14 | 95 | 3 | CID011469229 | |
| Drug | milacemide | 3.09e-05 | 15 | 95 | 3 | CID000053568 | |
| Drug | 7-chlorokynurenic acid | 3.72e-05 | 45 | 95 | 4 | CID000001884 | |
| Drug | zatosetron | 4.59e-05 | 17 | 95 | 3 | CID000060763 | |
| Drug | avermectin | 4.81e-05 | 48 | 95 | 4 | CID006450460 | |
| Drug | cyanotriphenylborate | 5.15e-05 | 3 | 95 | 2 | CID000151925 | |
| Drug | 7-chloro-4-quinolinol | 5.15e-05 | 3 | 95 | 2 | CID000066593 | |
| Drug | 5,7-dichlorokynurenic acid | 5.22e-05 | 49 | 95 | 4 | CID000001779 | |
| Drug | AC1L1CMQ | 6.50e-05 | 19 | 95 | 3 | CID000001968 | |
| Drug | PNU-120596 | 6.50e-05 | 19 | 95 | 3 | CID000311434 | |
| Drug | propanethiol | 7.62e-05 | 20 | 95 | 3 | CID000007848 | |
| Drug | di-Z | 7.62e-05 | 20 | 95 | 3 | CID000656933 | |
| Drug | glycine | 7.71e-05 | 169 | 95 | 6 | CID000000750 | |
| Drug | ethyltrimethylammonium | 8.86e-05 | 21 | 95 | 3 | CID000033993 | |
| Drug | meproadifen | 8.86e-05 | 21 | 95 | 3 | CID000189752 | |
| Drug | R 5135 | 8.86e-05 | 21 | 95 | 3 | CID000119544 | |
| Drug | nipecotic acid | 9.48e-05 | 57 | 95 | 4 | CID000004498 | |
| Drug | Z-Gly | 1.02e-04 | 22 | 95 | 3 | CID000014349 | |
| Drug | 2-hydroxysaclofen | 1.09e-04 | 59 | 95 | 4 | CID000001564 | |
| Drug | magnesium oxide | 1.17e-04 | 23 | 95 | 3 | CID000014792 | |
| Drug | CGP 35348 | 1.32e-04 | 62 | 95 | 4 | CID000107699 | |
| Drug | 1-chloro-1,2,2-trifluorocyclobutane | 1.34e-04 | 24 | 95 | 3 | CID000079091 | |
| Drug | dimethyl succinate | 1.34e-04 | 24 | 95 | 3 | CID000007820 | |
| Drug | AP-7 | 1.40e-04 | 63 | 95 | 4 | CID000003122 | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 1.64e-04 | 194 | 95 | 6 | 2086_DN | |
| Drug | V-X-A | 1.71e-04 | 26 | 95 | 3 | CID006369389 | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 6907_UP | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 5425_UP | |
| Drug | Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; HL60; HG-U133A | 1.88e-04 | 199 | 95 | 6 | 1383_UP | |
| Drug | enflurane | 1.89e-04 | 68 | 95 | 4 | CID000003226 | |
| Drug | pitrazepin | 1.91e-04 | 27 | 95 | 3 | CID000146222 | |
| Drug | phaclofen | 2.11e-04 | 70 | 95 | 4 | CID000001641 | |
| Drug | felbamate | 2.11e-04 | 70 | 95 | 4 | CID000003331 | |
| Drug | BN52020 | 2.14e-04 | 28 | 95 | 3 | CID000115221 | |
| Drug | pentylenetetrazol | 2.16e-04 | 130 | 95 | 5 | CID000005917 | |
| Drug | ifenprodil | 2.23e-04 | 71 | 95 | 4 | CID000003689 | |
| Disease | Hereditary hyperekplexia | 9.35e-05 | 5 | 91 | 2 | cv:C1835614 | |
| Disease | X-23756 measurement | 9.35e-05 | 5 | 91 | 2 | EFO_0022126 | |
| Disease | viral infectious disease (implicated_via_orthology) | 9.35e-05 | 5 | 91 | 2 | DOID:934 (implicated_via_orthology) | |
| Disease | Hereditary Hyperexplexia | 9.35e-05 | 5 | 91 | 2 | C1835614 | |
| Disease | Hyperekplexia | 1.40e-04 | 6 | 91 | 2 | cv:C0234166 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 3.34e-04 | 9 | 91 | 2 | EFO_0800562 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 7.18e-04 | 13 | 91 | 2 | EFO_0800474 | |
| Disease | hematologic cancer (implicated_via_orthology) | 7.18e-04 | 13 | 91 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | myeloid leukemia (is_implicated_in) | 7.18e-04 | 13 | 91 | 2 | DOID:8692 (is_implicated_in) | |
| Disease | cathepsin L1 measurement | 1.10e-03 | 16 | 91 | 2 | EFO_0010619 | |
| Disease | spine bone size | 1.39e-03 | 18 | 91 | 2 | EFO_0004508 | |
| Disease | Tourette syndrome, schizophrenia | 1.39e-03 | 18 | 91 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | Chronic myeloproliferative disorder | 1.55e-03 | 19 | 91 | 2 | C1292778 | |
| Disease | Seckel syndrome | 2.09e-03 | 22 | 91 | 2 | C0265202 | |
| Disease | Renal glomerular disease | 2.28e-03 | 23 | 91 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.28e-03 | 23 | 91 | 2 | C4521256 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LKYWPKTCTQKEVMF | 321 | Q15173 | |
| KTAMSLLWKSYPLVC | 376 | P23141 | |
| VIWKYPTMAKVAELK | 426 | Q12834 | |
| VSKMCPSDVYRVWKR | 136 | Q6ZTN6 | |
| VEWLDVKYCMPTSDK | 886 | Q8N7X0 | |
| IVGTTYVKCWTPDIM | 546 | O43506 | |
| TCIITPTAKAWKYME | 336 | Q8NEB7 | |
| LCIPRSDVMYTDWKK | 166 | P19652 | |
| LKCMVEWSKDLYVNP | 571 | Q9Y6D5 | |
| EKMITCVSWHPTIYG | 336 | Q8IWG1 | |
| KKFKLPVWETIVCTM | 66 | O00170 | |
| MFIKIHIPWDTLCKY | 206 | Q9BYT9 | |
| RLFELWMLYCTKKDP | 6 | Q6ZS30 | |
| KTIHWIKAPNYSCVM | 131 | P78406 | |
| LPGKYKISIMHEDWC | 551 | P69849 | |
| DKKTPTSIEYWFRCM | 386 | Q9Y5P8 | |
| SLPKVSYVKAIDIWM | 306 | O75311 | |
| PEYDIMCKVKSWVID | 181 | Q9NTK5 | |
| IPDKWKCYDALRKMI | 376 | P21953 | |
| YEIMVKCWNSEPEKR | 926 | P16234 | |
| LPGKYKISIMHEDWC | 551 | Q5JPE7 | |
| TLYLMEKKYSPCAWE | 151 | P01570 | |
| KAMECVWKQKLYEPV | 161 | P19878 | |
| VKPTITWYMGCYKIQ | 171 | Q9NPH3 | |
| GETQLMYKWAKPKIC | 346 | Q6UXG2 | |
| HVTSVEEWKCMYTPK | 411 | Q8N6G6 | |
| WILVQYCSKRPGMKE | 766 | Q63HM2 | |
| IAICKPLWYTMILTS | 126 | Q96RD3 | |
| VAICKPLSYTTIMNW | 116 | Q8NGF9 | |
| ASVMVYDDTSKKWVP | 11 | Q9UI08 | |
| MVCWPVNYRLSNAKK | 111 | Q6NV75 | |
| TLYLMEKKYSPCAWE | 151 | P01567 | |
| LTCIKLIKMYTWEKP | 346 | Q96J66 | |
| LPGKYKISIMHEDWC | 551 | Q15155 | |
| YSVMKTCPLSWVQRV | 586 | Q9P265 | |
| YFVEPKWLCKIMAQI | 1596 | Q5S007 | |
| NYDIKWTMPHCVLTL | 136 | Q6P1A2 | |
| PKCIVGKFRMYVAVW | 151 | P00488 | |
| YKWDMKCVHIPLESF | 146 | Q86XA0 | |
| KSCYEDGWLIKMTLS | 136 | P23434 | |
| DALTVDPTMYKCLWK | 126 | P48167 | |
| WIEEYKKQVFPIMCA | 176 | Q9BZ72 | |
| VECYNPKTKTWSVMP | 531 | Q96PQ7 | |
| TPCDEEGKTQIMYKW | 356 | A8MWY0 | |
| IMYKWIEPKICREDL | 366 | A8MWY0 | |
| YIVKYKEVCPWMQTV | 131 | Q9UMZ3 | |
| MYCAWLENPKSVHKS | 61 | Q02218 | |
| KKPSVVITWMSLDFY | 526 | Q13535 | |
| IMKKYKDVTACLPEW | 2021 | Q13535 | |
| MECYDIYSKTWTKQP | 391 | Q9H2C0 | |
| YDTVPVMWLKPCKRA | 3951 | Q8WXX0 | |
| MWGSSVFLCYKKSVP | 186 | Q5VZ89 | |
| IKFGPERMYIDCWVK | 356 | O00458 | |
| IMICVPTWAKESAPY | 201 | Q8N6P7 | |
| PTWAKESAPYMCRVK | 206 | Q8N6P7 | |
| TDYIKNLPMWRFKCL | 506 | O00237 | |
| PMIWATEYKHVDLVK | 876 | Q9H9B1 | |
| ALYLQMNEKKPTWIC | 371 | O75928 | |
| KWYKMVPCGKRVFAV | 806 | O60391 | |
| SWNILCKIIMAAYPA | 276 | P59535 | |
| AVKTLPTEAMWKCYI | 316 | Q9NYH9 | |
| QPWDMYKPLTKSCEI | 111 | Q9NYK5 | |
| YNMVPPKVKCLTKIW | 91 | Q969M7 | |
| KVWKISLQGPCYMTL | 346 | Q6UWJ1 | |
| LVDWKKYHLCMIPNL | 276 | Q8N6T0 | |
| DYRPMKECVWKITVS | 481 | O43897 | |
| FWYCMEHSKPVVLSL | 5296 | Q8WXH0 | |
| TLYLMGKKYSPCAWE | 151 | P05015 | |
| ICNPLLYTVTMSWKV | 126 | Q8NGL2 | |
| SLPKVSYVKAIDIWM | 301 | P23415 | |
| DVDPSWKKAIYKVIC | 701 | Q92786 | |
| HYKVTFPECVRWMTI | 2036 | O75592 | |
| ASWMKCPLDRAYLIK | 56 | Q9Y5N6 | |
| PSECTKEVKSLMWVY | 146 | P46721 | |
| CKEVEYKQLWMPFSV | 276 | Q9Y6Y8 | |
| PIYFGALIDTTCMKW | 541 | G3V0H7 | |
| LYIQMNEKKPTWVCP | 361 | O75925 | |
| YLTCKNGEWKPAMEI | 86 | Q92537 | |
| FPISIWMCIKIIKEY | 46 | P27105 | |
| GILGVCKITSKYWEM | 396 | Q86XI2 | |
| CKITSKYWEMMPPTI | 401 | Q86XI2 | |
| AAKFWKICPMEHILV | 491 | Q86XI2 | |
| KWLHFYEMKAPLVCL | 236 | Q9H0W9 | |
| CKLAYIEPYKRTMQW | 791 | Q9BXT8 | |
| CTQKYSPWGMKKVLL | 256 | Q9Y228 | |
| KVTEVLPWIYSKMEV | 546 | Q9BYE2 | |
| ITFPISIWMCLKIIK | 41 | Q8TAV4 | |
| PSEIYPLKMASEWKC | 256 | Q5VUG0 | |
| MCSYKLVTVKFEVWG | 181 | Q9UKF7 | |
| RKGKCPSSLYMAWLE | 981 | P55017 | |
| MLGTKHSYWICKPAE | 201 | Q9BWV7 | |
| MAPVSPEYWSKIKCK | 1411 | Q9BZ95 | |
| MPLWYLTKEKKDELC | 1131 | P11388 | |
| QWTLMTYVCDILKPF | 681 | P86452 | |
| IYCKRQFMEKKPSWS | 191 | Q9NS68 | |
| ALIYWFAPCSKMGKI | 421 | Q9Y210 | |
| MFTYNIPTCLATWKI | 1896 | O60293 | |
| PAICKSYLKLMTELW | 226 | Q8TEY7 | |
| QVEEWKCMYAPKPKV | 456 | P82987 | |
| YSWMDIITICKDKLP | 61 | Q9BV57 |